These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16237702)

  • 21. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
    Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
    Sotiropoulos GC; Molmenti EP; Omar OS; Bockhorn M; Brokalaki EI; Lang H; Frilling A; Broelsch CE; Malagó M
    Eur J Med Res; 2006 Nov; 11(11):467-70. PubMed ID: 17182358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases.
    Sotiropoulos GC; Molmenti EP; Lösch C; Beckebaum S; Broelsch CE; Lang H
    Eur J Med Res; 2007 Oct; 12(10):527-34. PubMed ID: 18024261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of hepatocellular carcinoma: is the jury still out?
    Morris-Stiff G; Gomez D; de Liguori Carino N; Prasad KR
    Surg Oncol; 2009 Dec; 18(4):298-321. PubMed ID: 19062271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
    Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.
    Roayaie S; Schwartz JD; Sung MW; Emre SH; Miller CM; Gondolesi GE; Krieger NR; Schwartz ME
    Liver Transpl; 2004 Apr; 10(4):534-40. PubMed ID: 15048797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation.
    Onaca N; Davis GL; Goldstein RM; Jennings LW; Klintmalm GB
    Liver Transpl; 2007 Mar; 13(3):391-9. PubMed ID: 17318865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic indicators for tumor recurrence after liver transplantation in hepatocellular carcinoma and related molecular targeted therapy.
    Yu L; Dai Z; Wang Z; Fan J; Zhou J
    Oncology; 2011; 81 Suppl 1():116-22. PubMed ID: 22212945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center.
    Lee SG; Hwang S; Moon DB; Ahn CS; Kim KH; Sung KB; Ko GY; Park KM; Ha TY; Song GW
    Liver Transpl; 2008 Jul; 14(7):935-45. PubMed ID: 18581465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
    Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
    Decaens T; Roudot-Thoraval F; Hadni-Bresson S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Sulpice L; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Cherqui D; Duvoux C
    Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of incidentally found hepatocellular carcinoma on the outcome of living donor liver transplantation.
    Kishi Y; Sugawara Y; Tamura S; Kaneko J; Kokudo N; Makuuchi M
    Transpl Int; 2006 Sep; 19(9):720-5. PubMed ID: 16918532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma.
    Cillo U; Vitale A; Brolese A; Zanus G; Neri D; Valmasoni M; Bonsignore P; Grigoletto F; Burra P; Farinati F; D'Amico DF
    J Surg Oncol; 2007 Mar; 95(3):213-20. PubMed ID: 17066432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria.
    Woo HY; Jang JW; Choi JY; You CR; Jeong SW; Bae SH; Yoon SK; Lee YS; Kim DG
    Liver Int; 2008 Sep; 28(8):1120-8. PubMed ID: 18492023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation for solitary hepatocellular carcinoma less than 3 cm in diameter in Child A cirrhosis.
    Poon RT
    Dig Dis; 2007; 25(4):334-40. PubMed ID: 17960069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: feasibility of the Milan criteria and operative risk.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3558-61. PubMed ID: 19100437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for hepatocellular carcinoma in Singapore.
    Wai CT; Lee YM; Wang SC; Da Costa M; Isaac J; Wee A; Lim SG
    Singapore Med J; 2006 Jul; 47(7):584-7. PubMed ID: 16810428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
    Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
    J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.